Aprepitant Capsule
Product Images NDC 68001-668

This text is a package description for Aprepitant Capsules, USP. It includes details such as the dosage, composition of each capsule (125 mg of aprepitant), storage instructions, manufacturer information, and the intended use for adults and pediatric patients aged 12 years and older. The carton size and bulk packaging details are also mentioned along with the prescription-only status of the medication.*

This is a product label for Aprepitant Capsules, USP, manufactured by BluePoint Laboratories. The capsules are prescribed for adults and pediatric patients 12 years of age and older. Each 125 mg capsule contains 125 mg of Aprepitant, and each 80 mg capsule contains 80 mg of Aprepitant. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). For dosing instructions, refer to the accompanying Prescribing Information. The label also displays contact information and a warning to keep all drugs out of the reach of children.*

This text provides information about Aprepitant Capsules, USP, containing 40 mg of aprepitant per capsule. It includes details on adult dosage, storage conditions, manufacturing information, and contact details for inquiries. The packaging is not child-resistant and comes in a carton size of 97 mm x 20 mm x 52 mm. The drug is manufactured by Glenmark Pharmaceuticals Limited in India for BluePoint Laboratories. The prescribed temperature range for storage is 20°C to 25°C.*

This is information about Aprepitant Capsules, USP. These capsules are used to prevent nausea and vomiting before chemotherapy. The artwork size for the packaging is 108 mm x 25 mm x 150 mm, and they contain 80 mg of aprepitant. The manufacturer is Glenmark Pharmaceuticals Limited in India, for BluePoint Laboratories. They should be stored at 20°C to 25°C. The medication is for adults and pediatric patients 12 years and older. The package contains two capsules to be taken on consecutive days. Consult the prescribing information for the correct dosage and keep all drugs out of the reach of children. For more information or questions, contact 1 (888) 721-7115. Visit www.glenmarkpharmaus.com.*

This is a medication packaging for Aprepitant capsules containing 80 mg of aprepitant, USP. The usual dosage is provided along with storage instructions. The manufacturer is identified as Glanmar Pharmaceuticals Pvt. Ltd. based in Mainya Pradesh, India. It is intended for both adults and pediatric patients aged 12 years and older. The packaging is designed for bulk use and is not meant for dispensing. The product is not child-resistant, and caution is advised to keep it out of reach of children.*

This information outlines the percentage of patients in two studies under an aprepitant regimen and standard therapy. Study 1 had a total of 260 patients receiving aprepitant and 263 patients under standard therapy. Study 2 included 261 patients on aprepitant and 261 on standard therapy. The given data may represent the distribution of patients across different time points in hours.*

The text provides information regarding two studies comparing the efficacy of an Aprepitant Regimen to Standard Therapy in chemotherapy cycles. Study 1 includes data on the number of patients receiving Aprepitant and Standard Therapy across different chemotherapy cycles. Study 2 displays a graphical representation of the data, showing the distribution of patients under each treatment regimen throughout the cycles.*